Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10408396 | 0.94 | TYMP (0.52) | TYMP | |
| SCHEMBL5438423 | 0.94 | TYMP (0.52) | TYMP | |
| SCHEMBL5443832 | 0.94 | TYMP (0.52) | TYMP | |
| SCHEMBL23113802 | 0.89 | TYMP (0.49) | TYMP | |
| SCHEMBL3194078 | 0.89 | TYMP (0.49) | TYMP | |
| SCHEMBL3194070 | 0.89 | TYMP (0.49) | TYMP | |
| SCHEMBL20502250 | 0.89 | PTPN1 (0.49) | TYMPSLC5A2 | |
| SCHEMBL23525559 | 0.89 | KIF11 (0.42) | TYMPSLC5A2 | |
| SCHEMBL8158741 | 0.88 | TYMP (0.48) | TYMPSLC5A2 | |
| SCHEMBL22033901 | 0.88 | TYMP (0.48) | TYMPSLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10441564-B2 | Fructose analogs and their combinations as anti-cancer agents | Jia, Wei (US) | 2019-10-15 | — | — | US | disclosed |
| US-20180133192-A1 | Fructose analogs and their combinations as anti-cancer agents | JIA, WEI | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180133192-A1 | Fructose analogs and their combinations as anti-cancer agents | ALDOA, FBP1, MPI | TYMP 1573/4885SLC5A2 10/4885 |
| US-10441564-B2 | Fructose analogs and their combinations as anti-cancer agents | ALDOA, FBP1, MPI | TYMP 1434/4885SLC5A2 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.